Pay in 4 interest-free payments of $7.09 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Zhou Y, Liyanage PY, Devadoss D, Rios Guevara LR, Cheng L, Graham RM, Chand HS, Al-Youbi AO, Bashammakh AS, El-Shahawi MS, Leblanc RM
FOXO4-DRI is a breakthrough "third-generation" senolytic peptide engineered to selectively eliminate senescent cells ("zombie cells") that accumulate with aging
Epithalon and DNA Activation and Gene Expression Epithalon is being actively researched to explore the mechanisms by which this peptide may mediate longevity
Weight Loss Membership, ongoing medically supervised weight care
Funding This study was partly funded by the Ministerio de Economa y Competitividad (BFU2016-79259-R
Category 2 These substances raised significant FDA safety concerns
